These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 14985112)
1. A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2. Wu X; Zhao R; Li Z; Yao M; Wang H; Han J; Qu S; Chen X; Qian L; Sun Y; Xu Y; Gu J Biochem Biophys Res Commun; 2004 Mar; 315(4):1004-10. PubMed ID: 14985112 [TBL] [Abstract][Full Text] [Related]
2. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. Barton WA; Tzvetkova-Robev D; Miranda EP; Kolev MV; Rajashankar KR; Himanen JP; Nikolov DB Nat Struct Mol Biol; 2006 Jun; 13(6):524-32. PubMed ID: 16732286 [TBL] [Abstract][Full Text] [Related]
3. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. Bogdanovic E; Nguyen VP; Dumont DJ J Cell Sci; 2006 Sep; 119(Pt 17):3551-60. PubMed ID: 16895971 [TBL] [Abstract][Full Text] [Related]
4. A novel gene delivery system targeting Tie2 for cancer gene therapy. Hu A; Wu X; Li Z; Wang H; Li J; Yao M; Chen X; Qu S; Xu Y; Gu J Anticancer Res; 2010 Jun; 30(6):1999-2004. PubMed ID: 20651343 [TBL] [Abstract][Full Text] [Related]
5. Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition. Barton WA; Tzvetkova D; Nikolov DB Structure; 2005 May; 13(5):825-32. PubMed ID: 15893672 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer. Sarraf-Yazdi S; Mi J; Moeller BJ; Niu X; White RR; Kontos CD; Sullenger BA; Dewhirst MW; Clary BM J Surg Res; 2008 May; 146(1):16-23. PubMed ID: 17950331 [TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells. Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy. Wu X; Li Z; Yao M; Wang H; Qu S; Chen X; Li J; Sun Y; Xu Y; Gu J Acta Biochim Biophys Sin (Shanghai); 2008 Mar; 40(3):217-25. PubMed ID: 18330476 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases. Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222 [TBL] [Abstract][Full Text] [Related]
11. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy. Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864 [TBL] [Abstract][Full Text] [Related]
12. Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice. DeNardo SJ; Yao Z; Lam KS; Song A; Burke PA; Mirick GR; Lamborn KR; O'Donnell RT; DeNardo GL Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3854S-64S. PubMed ID: 14506183 [TBL] [Abstract][Full Text] [Related]
13. Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis. Milner CS; Hansen TM; Singh H; Brindle NP Microvasc Res; 2009 Mar; 77(2):187-91. PubMed ID: 18848573 [TBL] [Abstract][Full Text] [Related]
14. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
16. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118 [TBL] [Abstract][Full Text] [Related]
17. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Bae DG; Kim TD; Li G; Yoon WH; Chae CB Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646 [TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat. Sandhu R; Teichert-Kuliszewska K; Nag S; Proteau G; Robb MJ; Campbell AI; Kuliszewski MA; Kutryk MJ; Stewart DJ Cardiovasc Res; 2004 Oct; 64(1):115-24. PubMed ID: 15364619 [TBL] [Abstract][Full Text] [Related]
19. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy. Shlamkovich T; Aharon L; Barton WA; Papo N Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724 [TBL] [Abstract][Full Text] [Related]
20. Design of a novel small peptide targeted against a tumor-specific receptor. Campa MJ; Kuan CT; O'Connor-McCourt MD; Bigner DD; Patz EF Biochem Biophys Res Commun; 2000 Aug; 275(2):631-6. PubMed ID: 10964715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]